about
Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor MicroenvironmentTarget of obstructive sleep apnea syndrome merge lung cancer: based on big data platform.Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer.Selective depletion of regulatory T cell subsets by docetaxel treatment in patients with nonsmall cell lung cancerTransduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.Graft-versus-host disease is enhanced by selective CD73 blockade in miceAlteration of renal cyclooxygenase expression due to partial unilateral ureteral obstruction in neonatal.TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumorsLong noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2.Hepatitis C virus core protein impairs metabolic disorder of liver cell via HOTAIR-Sirt1 signalling.Tumor-associated macrophages: from basic research to clinical application.Manipulating the expression of chemokine receptors enhances delivery and activity of cytokine-induced killer cells.Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.T-cell receptor-engineered T cells for cancer treatment: current status and future directions.Long-Peptide Cross-Presentation by Human Dendritic Cells Occurs in Vacuoles by Peptide Exchange on Nascent MHC Class I Molecules.Evaluation of combined argon plasma coagulation and Savary Bougienage for the relief of anastomotic-stenosis after esophageal squamous cancer surgery.Tumor-associated macrophages, potential targets for cancer treatment.Cancer immunology and cancer immunodiagnosis.CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targeting.Cancer Immunology and Cancer Immunodiagnosis 2016Gene function analysis and underlying mechanism of esophagus cancer based on microarray gene expression profiling.Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer.The expression of immediate early response gene X-1 in preeclampsia placenta and its pro-apoptotic role in preeclampsia.CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer.Immunotherapy with CAR-Modified T Cells: Toxicities and Overcoming Strategies.Future of anti-PD-1/PD-L1 applications: Combinations with other therapeutic regimens.Type 2 Innate Lymphoid Cells Impede IL-33-Mediated Tumor SuppressionPolarization of granulocytic myeloid-derived suppressor cells by hepatitis C core protein is mediated via IL-10/STAT3 signalingFates of CD8+ T cells in Tumor MicroenvironmentCD73 expression on effector T cells sustained by TGF-β facilitates tumor resistance to anti-4-1BB/CD137 therapyEpiscleritis in a patient with mucosal melanoma treated with interferon alfa-2b and radiotherapy: a case reportLow-dose IFN-γ induces tumor cell stemness in tumor microenvironment of non-small cell lung cancerTargeting NR4As, a new strategy to fine-tune CAR-T cells against solid tumorsGASC1 Promotes Stemness of Esophageal Squamous Cell Carcinoma via NOTCH1 Promoter DemethylationCancer-cell-secreted CXCL11 promoted CD8 T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLCTNF-α-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancerScreening common signaling pathways associated with drug resistance in non-small cell lung cancer via gene expression profile analysis.Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndromeDual TGF-β and PD-1 blockade synergistically enhances MAGE-A3-specific CD8+ T cell response in esophageal squamous cell carcinomaCCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency
P50
Q26740114-E66B92F9-B337-4BE8-9960-16CA279380B3Q33591607-DEE9AD70-153B-43AF-93FB-DE1098CE5F13Q33599094-39D2CB7A-0757-4ACB-A443-E45EAF8E1E81Q33608626-CB510D70-0433-49B6-A4FA-32255B5511B0Q33649735-ADA49D9F-7121-4D33-AD2F-AF53E454723EQ34631798-21450724-8340-470A-BACF-A27248D90E1FQ36728900-84102009-F681-4791-AF75-0B016CDAAA3FQ36951685-7DF6D868-583D-49ED-8609-3D1B6B78C51EQ37295457-4EE7EE63-ED90-4154-8B0B-58297ADBF05FQ37626812-CFF67AFD-94F6-4BB7-B45A-2BF47EB7F756Q37671174-6BCEC098-261B-4611-9C23-5C3347E2D3ADQ37711663-4A782466-DE08-4CCF-B7BC-B6DB74916EE3Q38656694-04ADCEEC-C23E-431D-B163-E87011C19508Q38767662-0BD79F19-E117-4E4E-9E3F-CD7D10BBD9EAQ38801145-E453A4EC-8CF8-4A4D-A6E9-3EC0814A7363Q39195971-4F691F07-CA15-4E71-9699-2E00706DFF8FQ41318642-5A9CC779-045C-4379-8B75-AC91237909F7Q41873032-41A560CD-5740-4AA7-9492-0EB84A8C2B1FQ42136462-5B015CD0-BC5F-4D8E-906B-82C1E83304EAQ42328385-38C6E0ED-AA37-4813-8523-3B87A249E639Q47161221-05B09FD7-EFA6-4264-99F4-BD3106C2657DQ48120429-E29954D1-BD95-4628-9303-EF013DCCBD9CQ50947662-D9317EF9-7638-4A95-8D83-3268F1645E5DQ52763511-FC5BC5A1-6F71-43E3-8B77-61E930DB8C9FQ55216327-1FEBF62F-23E7-462D-B65E-330C2897ACC4Q55262681-8F193EE0-6781-4562-AA40-ADB49ECD7D73Q58104422-638EF60D-632B-4DD2-AC7D-99A74A032374Q58588813-278F709D-2B7E-497E-9E5A-BE4283D19250Q60313339-D1BCB8F2-1944-4A79-B731-04633A58DE6AQ60912028-42C56C4C-465F-4895-9938-D3DDB55AD803Q60935613-FC46C998-E985-4B25-8559-203ECA02FD4EQ61227062-1BD00CA5-13AD-4482-8C8E-99BDE64C67C2Q64105513-DBC30E95-8540-413D-8257-5C43D14528A3Q64119874-ABA29E2F-AD7E-4642-AD17-594FC11C376DQ64237150-15103F39-18AA-4CC5-B49C-255AD8FBCE2DQ64272018-2FFEC4F3-9ABC-45F2-BECA-97029D31A703Q64946449-D2AEA3F3-9B46-4CE2-9256-305A3C8C0A32Q83509049-8A0B19A3-7C9F-43CF-A469-9250D781A3A5Q89451798-916633D8-6BBD-4428-B1F6-8B4212036AC1Q89881653-C51FDA34-58F7-4138-97D5-20EB55AAC48C
P50
description
researcher ORCID: 0000-0001-9861-4681
@en
name
Yi Zhang
@ast
Yi Zhang
@en
Yi Zhang
@nl
Yi Zhang
@sl
type
label
Yi Zhang
@ast
Yi Zhang
@en
Yi Zhang
@nl
Yi Zhang
@sl
prefLabel
Yi Zhang
@ast
Yi Zhang
@en
Yi Zhang
@nl
Yi Zhang
@sl
P108
P106
P108
P31
P496
0000-0001-9861-4681